Therapeutic options to minimize free radical damage and thrombogenicity in ischemic/reperfused myocardium.
Maza
S R
SR
Department of Medicine, Einstein College of Medicine, Bronx, N.Y.
Frishman
W H
WH
D000818:Animals; D003327:Coronary Disease / Q000378:metabolism* / Q000628:therapy*; D003328:Coronary Thrombosis / Q000378:metabolism*; D005609:Free Radicals; D006801:Humans; D010100:Oxygen / Q000378:metabolism*; D010477:Perfusion
D005609:Free Radicals; D010100:Oxygen